Zenotech Laboratories Share Price

CMP as on18-May-22 15:54

₹ 52.80
-1.2 -2.22%

Open

₹ 55.10

Turnover (lac)

₹ 18

Prev. Close

₹ 54.00

Day's Vol (shares)

₹ 11,193

Day's Range

₹ 52.25
₹ 57.00

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 22-Apr-2022 - -
Audited Results ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2022 ,inter alia, to consider and approve the Audited Standalone Financial Results of Zenotech Laboratories Limited (the Company) for the fourth quarter and year ended on March 31, 2022 Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, we enclose herewith the following: 1) the Standalone Audited Financial Results of the Company for the fourth quarter and financial year ended March 31, 2022 together with the Report of Auditors on the said Results, duly approved and taken on record by the Board of Directors of the Company at their meeting held today, i.e., April 29, 2022; and 2) Declaration under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting of the Board of Directors commenced at 5:50 PM and concluded at 8:30 PM. We would like to inform that Board of Directors of Zenotech Laboratories Limited (the Company) in their meeting held today i.e. on April 29, 2022 have considered and approved the request received from Daiichi Sankyo Company Limited (Daiichi) for reclassification from Promoter to Public Category. Please note that currently, Daiichi does not hold any shares in the Company and the reclassification will not impact the overall promoter holding in the Company. The Company shall seek shareholders approval for the reclassification in line with the provisions of Regulation 31A of SEBI Listing Regulations. As required under SEBI Listing Regulations, we also enclosed herewith as an Annexure - Extract of the minutes of Board Meeting, for your perusal. Request you to kindly take the same on record and oblige. (As Per BSE Announcement dated on 29.04.2022)
Board Meeting - 18-Jan-2022 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2022 inter alia to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31 2021. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, January 28, 2022, have approved and took on record the limited review Unaudited Standalone Financial Results of the Company for the quarter and nine months ended December 31, 2021, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 5:00 p.m. and concluded at 6:30 p.m. We request you to take the above on record. (As Per BSE Announcement Dated on 28.01.2022)
Board Meeting - 14-Oct-2021 - -
Quarterly Results ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2021 ,inter alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2021 Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Friday, October 22, 2021, have approved and took on record the limited review Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2021, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results. The meeting of the Board of Directors of the Company commenced at 4:00 p.m. and concluded at 6:30 p.m. We request you to take the above on record. (As Per BSE Announcement dated on 22.10.2021)
Board Meeting - 17-Jul-2021 - -
ZENOTECH LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/07/2021 ,inter alia, to consider and approve the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2021. Pursuant to the provisions of Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the Company at its meeting held today, i.e. Saturday, July 24, 2021, have duly approved and took on record the Unaudited Standalone Financial Results of the Company for the quarter ended June 30, 2021, which are enclosed herewith along with the Limited Review Report of the Statutory Auditors of the Company on Standalone Unaudited Financial Results for the quarter ended June 30, 2021. The meeting of the Board of Directors of the Company commenced at 11:00 a.m. and concluded at 3:30 p.m. We request you to take the above on record. (As Per BSE Announcement dated on 24.07.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity